Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)

-28.58% (1Y)

Market Cap	8.07B
Revenue (ttm)	2.36B
Net Income (ttm)	154.04M
Shares Out	249.40M
EPS (ttm)	0.66
PE Ratio	48.98
Forward PE	28.59
Dividend	0.25 (0.77%)
Ex-Dividend Date	Jul 10, 2025

Volume	2,748,875
Average Volume	2,423,556
Open	32.54
Previous Close	32.36
Day's Range	32.11 - 33.14
52-Week Range	25.60 - 47.64
Beta	0.01
RSI	54.96
Earnings Date	Aug 28, 2025

About SHA:688639

Anhui Huaheng Biotechnology Co., Ltd. engages in the development, production, and sale of amino acids and other organic acids in China and internationally. The company offers inositol, D-calcium pantothenate, L-valine, DL- alanine, L-citrulline, DL-malic acid, L-alanine, D-panthenol, L-citrulline DL-malate, L-malic acid, beta-alanine, α- arbutin, L-arginine, β-arbutin, L-glycine, L-proline, amino acid concentrate, compound amino acid power, microbial inoculum, compound microbial fertilizer, and water soluble fertilizer products. Its products ar...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2005
• Employees: 2,191
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688639

Financial Performance

In 2024, SHA:688639's revenue was 2.18 billion, an increase of 12.37% compared to the previous year's 1.94 billion. Earnings were 189.52 million, a decrease of -57.80%.